Yuichi Ishikawa

34.2k total citations · 5 hit papers
265 papers, 17.9k citations indexed

About

Yuichi Ishikawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yuichi Ishikawa has authored 265 papers receiving a total of 17.9k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Pulmonary and Respiratory Medicine, 109 papers in Oncology and 79 papers in Molecular Biology. Recurrent topics in Yuichi Ishikawa's work include Lung Cancer Treatments and Mutations (74 papers), Lung Cancer Research Studies (51 papers) and Lung Cancer Diagnosis and Treatment (36 papers). Yuichi Ishikawa is often cited by papers focused on Lung Cancer Treatments and Mutations (74 papers), Lung Cancer Research Studies (51 papers) and Lung Cancer Diagnosis and Treatment (36 papers). Yuichi Ishikawa collaborates with scholars based in Japan, India and United States. Yuichi Ishikawa's co-authors include Hiroyuki Mano, Manabu Soda, Young Lim Choi, Ken Nakagawa, Yoshihiro Yamashita, Sakae Okumura, Shuji Takada, Yukitoshi Satoh, Kengo Takeuchi and Munehiro Enomoto and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Yuichi Ishikawa

256 papers receiving 17.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

2007 4.0k citations Manabu Soda, Young Lim Choi et al. profile →
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

2013 1.7k citations Shin Yoshimoto, Yuichi Ishikawa et al. profile →
RET, ROS1 and ALK fusions in lung cancer

2012 963 citations Kengo Takeuchi, Manabu Soda et al. profile →
EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors

2010 915 citations Young Lim Choi, Manabu Soda et al. profile →
KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer

2009 557 citations Kengo Takeuchi, Young Lim Choi et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuichi Ishikawa Japan	53	9.7k	8.8k	7.5k	3.8k	2.2k	265	17.9k
Camillo Porta Italy	57	12.2k 1.3×	7.0k 0.8×	10.0k 1.3×	5.8k 1.5×	1.8k 0.8×	576	21.1k
Yoshitaka Fujii Japan	58	9.1k 0.9×	8.3k 0.9×	7.7k 1.0×	4.0k 1.0×	1.2k 0.6×	439	19.9k
Nobuyuki Yamamoto Japan	58	12.5k 1.3×	11.6k 1.3×	4.0k 0.5×	2.5k 0.7×	1.2k 0.6×	574	17.3k
Filip Jankú United States	58	4.4k 0.4×	6.0k 0.7×	6.7k 0.9×	4.3k 1.1×	1.2k 0.5×	430	14.9k
Hedy L. Kindler United States	61	7.3k 0.8×	8.4k 1.0×	3.6k 0.5×	3.1k 0.8×	1.2k 0.6×	400	16.1k
Emilio Bajetta Italy	55	5.8k 0.6×	10.4k 1.2×	3.9k 0.5×	3.7k 1.0×	2.4k 1.1×	325	16.6k
Bin Tean Teh United States	71	4.3k 0.4×	3.9k 0.4×	7.8k 1.0×	3.7k 1.0×	2.1k 1.0×	354	15.0k
Gabriella Fontanini Italy	56	4.7k 0.5×	7.2k 0.8×	5.3k 0.7×	2.7k 0.7×	955 0.4×	320	13.4k
Stefano Cascinu Italy	63	7.3k 0.7×	11.2k 1.3×	4.2k 0.6×	3.4k 0.9×	1.2k 0.5×	648	18.3k
Julian R. Molina United States	44	8.2k 0.8×	10.5k 1.2×	6.2k 0.8×	3.3k 0.9×	1.0k 0.5×	216	18.3k

Countries citing papers authored by Yuichi Ishikawa

Since Specialization

Citations

This map shows the geographic impact of Yuichi Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Ishikawa more than expected).

Fields of papers citing papers by Yuichi Ishikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichi Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Ishikawa. The network helps show where Yuichi Ishikawa may publish in the future.

Co-authorship network of co-authors of Yuichi Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Ishikawa. A scholar is included among the top collaborators of Yuichi Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Ishikawa. Yuichi Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Honma, Naoko, Tomio Arai, Yoko Matsuda, et al.. (2023). Estrogen Receptor-β Gene Cytosine-Adenine (ESR2-CA) Repeat Polymorphism in Postmenopausal Colon Cancer. International Journal of Molecular Sciences. 24(5). 4502–4502. 2 indexed citations

Kuwata, Takeshi, Masashi Wakabayashi, Yutaka Hatanaka, et al.. (2020). Impact of DNA integrity on the success rate of tissue‐based next‐generation sequencing: Lessons from nationwide cancer genome screening project SCRUM‐Japan GI‐SCREEN. Pathology International. 70(12). 932–942. 22 indexed citations

Fukuda, Koji, Shinji Takeuchi, Sachiko Arai, et al.. (2019). Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status. Cancer Research. 79(7). 1658–1670. 79 indexed citations

Matsuura, Yosuke, Junji Ichinose, Masayuki Nakao, et al.. (2019). <p>Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection</p>. Cancer Management and Research. Volume 11. 6765–6774. 18 indexed citations

Hino, Rumi, Noriko Motoi, Aya Ebina, et al.. (2018). Stromal tiny black dots, like “sugar‐coated”, of von Kossa stain is a diagnostic clue to hyalinizing trabecular tumor of the thyroid gland. Pathology International. 68(3). 176–182. 5 indexed citations

Ohishi, Tomokazu, Haruka Yoshida, Masamichi Katori, et al.. (2017). Tankyrase-Binding Protein TNKS1BP1 Regulates Actin Cytoskeleton Rearrangement and Cancer Cell Invasion. Cancer Research. 77(9). 2328–2338. 32 indexed citations

Oishi, Naoki, Tetsuo Kondo, Aya Ebina, et al.. (2017). Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation. Modern Pathology. 30(11). 1527–1537. 82 indexed citations

Suzuki, Makoto, Hitonobu Tomoike, Tetsuya Sumiyoshi, et al.. (2017). Incidence of cancers in patients with atherosclerotic cardiovascular diseases. IJC Heart & Vasculature. 17. 11–16. 35 indexed citations

Mashima, Tetsuo, Toshiro Migita, Takeshi Yuasa, et al.. (2014). TRIB1 Supports Prostate Tumorigenesis and Tumor-Propagating Cell Survival by Regulation of Endoplasmic Reticulum Chaperone Expression. Cancer Research. 74(17). 4888–4897. 38 indexed citations

10.

Takeuchi, Kengo, Manabu Soda, Yuki Togashi, et al.. (2011). Pulmonary Inflammatory Myofibroblastic Tumor Expressing a Novel Fusion, PPFIBP1–ALK: Reappraisal of Anti-ALK Immunohistochemistry as a Tool for Novel ALK Fusion Identification. Clinical Cancer Research. 17(10). 3341–3348. 77 indexed citations

11.

Dan, Shingo, Mutsumi Okamura, Kanami Yamazaki, et al.. (2010). Correlating Phosphatidylinositol 3-Kinase Inhibitor Efficacy with Signaling Pathway Status: In silico and Biological Evaluations. Cancer Research. 70(12). 4982–4994. 91 indexed citations

12.

Takahashi, Akiko, Noriko Motoi, Shin Yoshimoto, et al.. (2010). Intrinsic Cooperation between p16INK4a and p21Waf1/Cip1 in the Onset of Cellular Senescence and Tumor Suppression In vivo. Cancer Research. 70(22). 9381–9390. 94 indexed citations

13.

Nishimori, Hisakazu, Shunji Takahashi, Katsuyuki Kiura, et al.. (2010). Cancer of unknown primary site: a review of 28 cases and the efficacy of cisplatin/docetaxel therapy at a single institute in Japan.. PubMed. 64(5). 285–91. 5 indexed citations

14.

Takeuchi, Kengo, Young Lim Choi, Yuki Togashi, et al.. (2009). KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer. Clinical Cancer Research. 15(9). 3143–3149. 557 indexed citations breakdown →

15.

Choi, Young Lim, Kengo Takeuchi, Manabu Soda, et al.. (2008). Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non–Small Cell Lung Cancer. Cancer Research. 68(13). 4971–4976. 346 indexed citations

16.

Soda, Manabu, Shuji Takada, Kengo Takeuchi, et al.. (2008). A mouse model for EML4-ALK -positive lung cancer. Proceedings of the National Academy of Sciences. 105(50). 19893–19897. 396 indexed citations

17.

Takeuchi, Kengo, Young Lim Choi, Manabu Soda, et al.. (2008). Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts. Clinical Cancer Research. 14(20). 6618–6624. 397 indexed citations

18.

Hiramatsu, Miyako, Hironori Ninomiya, Kentaro Inamura, et al.. (2007). EGFR signal pathways selectively activated in lung adenocarcinoma.. Cancer Research. 67. 5038–5038. 1 indexed citations

19.

Hiramatsu, Miyako, Takuya Inagaki, Yoshio Matsui, et al.. (2007). Appropriate Follow-up Interval of Thin Section CT Scan for Evaluating Pure Ground Glass Opacities of 10 mm or Less in the Lung Field. Haigan. 47(1). 27–35. 1 indexed citations

20.

Igarashi, Yasuhito, Yuichi Ishikawa, Yuichi Takaku, et al.. (1991). Concentrations of Th and U in Human Tissues Determined by Inductively Coupled Plasma-Mass Spectrometry.. RADIOISOTOPES. 40(6). 226–233. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact